Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00768924 · ClinicalTrials.gov registry record
CopiOs(TM) Bone Void Filler in the Post-Harvest Iliac Crest
A clinical trial, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 35
- Enrollment target
NCT00768924: Completed study, sponsored by Zimmer Biomet.
NCT00768924 is a clinical trial that has completed, run by Zimmer Biomet. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00768924 has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The CopiOs Bone Void Filler (BVF) is a synthetic bone graft material consisting of calcium phosphate dehydrate within lyophilized type I bovine collagen that has been formed into pads of various sizes for surgical implantation. Pre-clinical animal studies suggest that the bone healing strength of CopiOs to be equivalent to autograft.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-12 |
What the finished NCT00768924 record still lists
NCT00768924 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00768924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00768924 about?
NCT00768924 is a clinical study titled "CopiOs(TM) Bone Void Filler in the Post-Harvest Iliac Crest". The CopiOs Bone Void Filler (BVF) is a synthetic bone graft material consisting of calcium phosphate dehydrate within lyophilized type I bovine collagen that has been formed into pads of various sizes for surgical implantation. Pre-clinical animal studies suggest that the bone healing strength of Co...
What is the current status of trial NCT00768924?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2007-03. Estimated completion is 2008-12.
Who is sponsoring clinical trial NCT00768924?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia